<DOC>
	<DOCNO>NCT00002327</DOCNO>
	<brief_summary>To evaluate safety tolerance topical cidofovir ( HPMPC ) therapy condyloma acuminatum patient HIV infection . To investigate whether topical HPMPC therapy induce regression condyloma acuminatum patient HIV infection .</brief_summary>
	<brief_title>The Safety Effectiveness Cidofovir Treatment Venereal Warts HIV-Infected Patients</brief_title>
	<detailed_description>Four group 10 patient receive topical HPMPC 0.3 percent concentration 5 10 day total 1.0 percent concentration 5 10 day total , follow 2 week rest . When six patient give dose schedule complete treatment follow-up without significant toxicity , subsequent patient enter next high dose level . Patients evaluate twice weekly treatment weekly rest period . HPMPC may extend two additional course patient experience significant toxicity .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : AZT , ddI , ddC , d4T , 3TC . Oral trimethoprim/sulfamethoxazole . Aerosolized pentamidine . Dapsone . Fluconazole . Rifabutin . Clarithromycin . Patients must : HIV seropositivity . Mean CD4 count &gt; = 100 cells/mm3 . External anogenital condyloma acuminatum confirm biopsy , present less 1 year . NOTE : Warts anal , urethral , vaginal mucosa study . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Active lesion genital herpes , skin wound , active inflammatory skin disorder area wart treat . Active medical problem sufficient hinder study compliance . Concurrent Medication : Excluded : Podofilox podophyllum resin preparation . Liquid nitrogen treatment . Interferon alpha . Trichloracetic acid . Other treatment , topical systemic , surgical ablative , know antipapilloma activity . Other investigative drug ( except d4T 3TC ) unless approve sponsor . Patients follow prior condition exclude : History untreated syphilis Bowenoid papulosis . Prior Medication : Excluded within 4 week prior study entry : Treatment anogenital wart . Immunomodulators ( include interferon systemic corticosteroid ) . Lymphocyte replacement therapy . Biologic response modifier . Substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1997</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Condylomata Acuminata</keyword>
	<keyword>cidofovir</keyword>
</DOC>